PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ARQT vs. DELL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ARQT and DELL is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

ARQT vs. DELL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcutis Biotherapeutics, Inc. (ARQT) and Dell Technologies Inc. (DELL). The values are adjusted to include any dividend payments, if applicable.

0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February
45.57%
8.21%
ARQT
DELL

Key characteristics

Sharpe Ratio

ARQT:

1.25

DELL:

0.33

Sortino Ratio

ARQT:

2.10

DELL:

0.95

Omega Ratio

ARQT:

1.24

DELL:

1.12

Calmar Ratio

ARQT:

1.15

DELL:

0.40

Martin Ratio

ARQT:

4.52

DELL:

0.75

Ulcer Index

ARQT:

21.51%

DELL:

27.07%

Daily Std Dev

ARQT:

77.19%

DELL:

60.77%

Max Drawdown

ARQT:

-95.02%

DELL:

-58.64%

Current Drawdown

ARQT:

-64.58%

DELL:

-42.64%

Fundamentals

Market Cap

ARQT:

$1.53B

DELL:

$70.94B

EPS

ARQT:

-$1.67

DELL:

$5.73

Total Revenue (TTM)

ARQT:

$125.18M

DELL:

$71.64B

Gross Profit (TTM)

ARQT:

$112.96M

DELL:

$15.42B

EBITDA (TTM)

ARQT:

-$109.21M

DELL:

$3.04B

Returns By Period

In the year-to-date period, ARQT achieves a -5.96% return, which is significantly higher than DELL's -11.42% return.


ARQT

YTD

-5.96%

1M

-10.40%

6M

45.56%

1Y

117.61%

5Y*

-11.99%

10Y*

N/A

DELL

YTD

-11.42%

1M

-14.87%

6M

8.21%

1Y

20.40%

5Y*

32.65%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ARQT vs. DELL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARQT
The Risk-Adjusted Performance Rank of ARQT is 8181
Overall Rank
The Sharpe Ratio Rank of ARQT is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of ARQT is 8282
Sortino Ratio Rank
The Omega Ratio Rank of ARQT is 7777
Omega Ratio Rank
The Calmar Ratio Rank of ARQT is 8282
Calmar Ratio Rank
The Martin Ratio Rank of ARQT is 7979
Martin Ratio Rank

DELL
The Risk-Adjusted Performance Rank of DELL is 5959
Overall Rank
The Sharpe Ratio Rank of DELL is 5959
Sharpe Ratio Rank
The Sortino Ratio Rank of DELL is 5858
Sortino Ratio Rank
The Omega Ratio Rank of DELL is 5757
Omega Ratio Rank
The Calmar Ratio Rank of DELL is 6565
Calmar Ratio Rank
The Martin Ratio Rank of DELL is 5656
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ARQT vs. DELL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcutis Biotherapeutics, Inc. (ARQT) and Dell Technologies Inc. (DELL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ARQT, currently valued at 1.25, compared to the broader market-2.000.002.004.001.250.33
The chart of Sortino ratio for ARQT, currently valued at 2.10, compared to the broader market-4.00-2.000.002.004.002.100.95
The chart of Omega ratio for ARQT, currently valued at 1.24, compared to the broader market0.501.001.502.001.241.12
The chart of Calmar ratio for ARQT, currently valued at 1.15, compared to the broader market0.002.004.006.001.150.40
The chart of Martin ratio for ARQT, currently valued at 4.52, compared to the broader market-10.000.0010.0020.004.520.75
ARQT
DELL

The current ARQT Sharpe Ratio is 1.25, which is higher than the DELL Sharpe Ratio of 0.33. The chart below compares the historical Sharpe Ratios of ARQT and DELL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.002.004.006.00SeptemberOctoberNovemberDecember2025February
1.25
0.33
ARQT
DELL

Dividends

ARQT vs. DELL - Dividend Comparison

ARQT has not paid dividends to shareholders, while DELL's dividend yield for the trailing twelve months is around 1.75%.


TTM202420232022
ARQT
Arcutis Biotherapeutics, Inc.
0.00%0.00%0.00%0.00%
DELL
Dell Technologies Inc.
1.75%1.48%1.88%2.46%

Drawdowns

ARQT vs. DELL - Drawdown Comparison

The maximum ARQT drawdown since its inception was -95.02%, which is greater than DELL's maximum drawdown of -58.64%. Use the drawdown chart below to compare losses from any high point for ARQT and DELL. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%SeptemberOctoberNovemberDecember2025February
-64.58%
-42.64%
ARQT
DELL

Volatility

ARQT vs. DELL - Volatility Comparison

Arcutis Biotherapeutics, Inc. (ARQT) has a higher volatility of 18.93% compared to Dell Technologies Inc. (DELL) at 14.09%. This indicates that ARQT's price experiences larger fluctuations and is considered to be riskier than DELL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February
18.93%
14.09%
ARQT
DELL

Financials

ARQT vs. DELL - Financials Comparison

This section allows you to compare key financial metrics between Arcutis Biotherapeutics, Inc. and Dell Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab